Skip to Navigation
Skip to Main Content
Skip to Related Content

Advertisement

U.S. markets close in 5 hours 14 minutes

S&P 500
6,005.10
-16.53(-0.27%)
Dow 30
44,916.27
+55.96(+0.12%)
Nasdaq
19,024.92
-150.66(-0.79%)
Russell 2000
2,430.48
+6.17(+0.25%)
Crude Oil
68.68
-0.09(-0.13%)
Gold
2,665.30
+19.00(+0.72%)

Emergent BioSolutions Inc. (EBS)

NYSE - Nasdaq Real Time Price. Currency in USD

Follow

Visitors trend2W10W9M

9.91

-0.11

(-1.15%)

As of 10:47AM EST. Market open.

Currency in USD

Valuation Measures⁴

Market Cap (intraday)	543.47M
Enterprise Value	1.06B
Trailing P/E	N/A
Forward P/E	N/A
PEG Ratio (5 yr expected)	N/A
Price/Sales (ttm)	0.48
Price/Book (mrq)	1.07
Enterprise Value/Revenue	0.97
Enterprise Value/EBITDA	51.52

Trading Information

Stock Price History

Beta (5Y Monthly)	1.57
52-Week Change ³	366.51%
S&P500 52-Week Change ³	32.33%
52 Week High ³	15.10
52 Week Low ³	1.42
50-Day Moving Average ³	8.90
200-Day Moving Average ³	6.59

Share Statistics

Avg Vol (3 month) ³	1.88M
Avg Vol (10 day) ³	1.51M
Shares Outstanding ⁵	54.18M
Implied Shares Outstanding ⁶	54.18M
Float ⁸	53.12M
% Held by Insiders ¹	2.09%
% Held by Institutions ¹	59.91%
Shares Short (Nov 15, 2024) ⁴	6.81M
Short Ratio (Nov 15, 2024) ⁴	4.42
Short % of Float (Nov 15, 2024) ⁴	15.28%
Short % of Shares Outstanding (Nov 15, 2024) ⁴	12.57%
Shares Short (prior month Oct 15, 2024) ⁴	7.79M

Dividends & Splits

Forward Annual Dividend Rate ⁴	N/A
Forward Annual Dividend Yield ⁴	N/A
Trailing Annual Dividend Rate ³	0.00
Trailing Annual Dividend Yield ³	0.00%
5 Year Average Dividend Yield ⁴	N/A
Payout Ratio ⁴	0.00%
Dividend Date ³	N/A
Ex-Dividend Date ⁴	N/A
Last Split Factor ²	N/A
Last Split Date ³	N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends	Dec 31, 2023
Most Recent Quarter (mrq)	Sep 30, 2024

Profitability

Profit Margin	-18.55%
Operating Margin (ttm)	24.51%

Management Effectiveness

Return on Assets (ttm)	-4.22%
Return on Equity (ttm)	-34.64%

Income Statement

Revenue (ttm)	1.13B
Revenue Per Share (ttm)	21.45
Quarterly Revenue Growth (yoy)	8.60%
Gross Profit (ttm)	N/A
EBITDA	-4.8M
Net Income Avi to Common (ttm)	-208.8M
Diluted EPS (ttm)	-3.91
Quarterly Earnings Growth (yoy)	N/A

Balance Sheet

Total Cash (mrq)	149.9M
Total Cash Per Share (mrq)	2.77
Total Debt (mrq)	676M
Total Debt/Equity (mrq)	132.97%
Current Ratio (mrq)	2.88
Book Value Per Share (mrq)	9.40

Cash Flow Statement

Operating Cash Flow (ttm)	170.7M
Levered Free Cash Flow (ttm)	89.59M